A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452

Feitsma, E. A., Janssen, Y. F., Boersma, H. H., van Sleen, Y., van Baarle, D., Alleva, D. G., Lancaster, T. M., Sathiyaseelan, T., Murikipudi, S., Delpero, A. R., Scully, M. M., Ragupathy, R., Kotha, S., Haworth, J. R., Shah, N. J., Rao, V., Nagre, S., Ronca, S. E., Green, F. M., Aminetzah, A., & 5 anderenSollie, F., Kruijff, S., Brom, M., van Dam, G. M. & Zion, T. C., 24-mrt.-2023, In: Vaccine. 41, 13, blz. 2184-2197 14 blz.

Onderzoeksoutput › Academic › peer review

Heterogeneity in Utilization of Optical Imaging Guided Surgery for Identifying or Preserving the Parathyroid Glands-A Meta-Narrative Review

Feitsma, E. A., Schouw, H. M., Noltes, M. E., Heeman, W., Kelder, W., van Dam, G. M. & Kruijff, S., 8-mrt.-2022, In: Life. 12, 3, 19 blz., 388.

Onderzoeksoutput › peer review

Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452

Janssen, Y. F., Feitsma, E. A., Boersma, H. H., Alleva, D. G., Lancaster, T. M., Sathiyaseelan, T., Murikipudi, S., Delpero, A. R., Scully, M. M., Ragupathy, R., Kotha, S., Haworth, J. R., Shah, N. J., Rao, V., Nagre, S., Ronca, S. E., Green, F. M., Aminetzah, A., Sollie, F., Kruijff, S., & 3 anderenBrom, M., van Dam, G. M. & Zion, T. C., 23-feb.-2022, In: Vaccine. 40, 9, blz. 1253-1260 8 blz.

Onderzoeksoutput › Academic › peer review